Profile data is unavailable for this security.
About the company
Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is engaged in offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. It focuses on supporting the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas, such as infectious disease, clinical testing including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. It also specializes in meeting compliance requirements in the international IVD and medical device markets.
- Revenue in GBP (TTM)5.34m
- Net income in GBP-2.24m
- Incorporated2008
- Employees82.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 19 0440 6050Fax+44 19 0446 2122
- Websitehttps://www.abingdonhealth.com/
Mergers & acquisitions
Acquired company | ABDX:LSE since announced | Transaction value |
---|---|---|
Compliance Solutions Group LLC | -13.95% | 4.12m |
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Rua Life Sciences PLC | 2.19m | -1.44m |
Genincode PLC | 2.60m | -5.94m |
Genedrive PLC | 272.00k | -5.00m |
Renalytix PLC | 2.59m | -35.24m |
Verici DX PLC | 3.30m | -3.67m |
Inspiration Healthcare Group PLC | 34.30m | -9.76m |
Polarean Imaging PLC | 1.42m | -6.52m |
Ondine Biomedical Inc | 917.99k | -8.02m |
Abingdon Health PLC | 5.34m | -2.24m |
Belluscura PLC | 1.38m | -14.18m |
ANGLE plc | 2.02m | -18.03m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 2023 | 10.43m | 8.23% |
Unicorn Asset Management Ltd.as of 31 Jul 2024 | 1.93m | 1.52% |